The leukotrienes: mediators of chronic inflammation in asthma
- 1 September 1996
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 26 (9) , 995-1004
- https://doi.org/10.1046/j.1365-2222.1996.d01-403.x
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Tumor necrosis factor cytotoxicity is associated with phospholipase D activationEuropean Journal of Biochemistry, 1993
- Leukotriene B4 transcriptionally activates interleukin‐6 expression involving NK‐xB and NF‐IL6European Journal of Immunology, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Effect of a peptide leukotriene antagonist, ONO-1078 on antigen-induced airway microvascular leakage in actively sensitized guinea pigsLife Sciences, 1992
- Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthmaJournal of Allergy and Clinical Immunology, 1991
- Peptide Leukotriene Involvement in Pulmonary Eosinophil Migration upon Antigen Challenge in the Actively Sensitized Guinea PigInternational Archives of Allergy and Immunology, 1991
- Leukotriene C elimination and metabolism in manJournal of Allergy and Clinical Immunology, 1990
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- Increased Generation of Leukotriene C4 from Eosinophils in Asthmatic PatientsAllergy, 1985
- BRONCHOCONSTRICTION PRODUCED IN MAN BY LEUKOTRIENES C AND DThe Lancet, 1981